10x Genomics Inc (NASDAQ: TXG) is -74.43% lower on its value in year-to-date trading and has touched a low of $12.95 and a high of $57.90 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TXG stock was last observed hovering at around $13.29 in the last trading session, with the day’s gains setting it 1.02%.
Currently trading at $14.31, the stock is -6.06% and -18.54% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.61 million and changing 7.67% at the moment leaves the stock -43.29% off its SMA200. TXG registered -66.99% loss for a year compared to 6-month loss of -36.65%. The firm has a 50-day simple moving average (SMA 50) of $17.5668 and a 200-day simple moving average (SMA200) of $25.2323.
The stock witnessed a -7.50% gain in the last 1 month and extending the period to 3 months gives it a -37.24%, and is 7.27% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.91% over the week and 6.27% over the month.
10x Genomics Inc (TXG) has around 1259 employees, a market worth around $1.87B and $629.74M in sales. Profit margin for the company is -28.99%. Distance from 52-week low is 10.50% and -75.28% from its 52-week high. The company has generated returns on investments over the last 12 months (-22.84%).
with sales reaching $153.46M over the same period.The EPS is expected to grow by 35.26% this year, but quarterly earnings will post -3.13% year-over-year. Quarterly sales are estimated to shrink -16.59% in year-over-year returns.
10x Genomics Inc (TXG) Top Institutional Holders
375.0 institutions hold shares in 10x Genomics Inc (TXG), with institutional investors hold 96.51% of the company’s shares. The shares outstanding are 105.04M, and float is at 99.73M with Short Float at 7.63%. Institutions hold 94.42% of the Float.
The top institutional shareholder in the company is FMR LLC with over 13.01 million shares valued at $253.05 million. The investor’s holdings represent 10.8971% of the TXG Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 10.19 million shares valued at $198.18 million to account for 8.5341 of the shares outstanding. The other top investors are ARK INVESTMENT MANAGEMENT LLC which holds 9.31 million shares representing 7.8009% and valued at over $181.15 million, while BLACKROCK INC. holds 5.3542 of the shares totaling 6.39 million with a market value of $124.34 million.
10x Genomics Inc (TXG) Insider Activity
#####
Still, SEC filings show that on Aug 22 ’24, Saxonov Serge (Chief Executive Officer) disposed off 6,749 shares at an average price of $22.53 for $0.15 million. The insider now directly holds 882,467 shares of 10x Genomics Inc (TXG).
